A promising tool: triglycerides–glucose index to stratify the risk of cardiovascular events in chronic kidney disease | Zendy

Fatma Yıldırım | Zendy; Abdullah Burak Yıldız | Zendy; Mehmet Kanbay | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A promising tool: triglycerides–glucose index to stratify the risk of cardiovascular events in chronic kidney disease

Author(s) -

Fatma Yıldırım,

Abdullah Burak Yıldız,

Mehmet Kanbay

Publication year - 2022

Publication title -

clinical kidney journal

Language(s) - English

Resource type - Journals

eISSN - 2048-8513

pISSN - 2048-8505

DOI - 10.1093/ckj/sfac084

Subject(s) - medicine , kidney disease , diabetes mellitus , peritoneal dialysis , dialysis , metabolic syndrome , disease , population , cholesterol , triglyceride , lipid metabolism , intensive care medicine , endocrinology , cardiology , environmental health

Lipid profile management is one of the crucial components to optimize outcomes in patients with chronic kidney disease (CKD). CKD is associated with poor cardiovascular outcomes due to both a direct cardiovascular impact of CKD and the presence of metabolic comorbidities. Low-density lipoprotein cholesterol is the main target of current lipid-lowering drugs. However, the derangement of lipid metabolism in CKD is more complex. The recently described triglyceride glucose index (TyG) is associated with cardiovascular outcomes in the general population. In recent studies, TyG was associated with CKD progression in CKD patients and with cardiovascular death in patients on peritoneal dialysis. Quiroga et al. now show that the TyG is associated with the occurrence of major cardiovascular events in individuals free from diabetes with non-dialysis dependent CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research